SEC Form 4 · accession 0001193125-26-267560
Bolt Biotherapeutics, Inc. · BOLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura Berner
Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 11, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001641281
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.43 | Jun 10, 2026 | A | 5,000 | A | — | Jun 9, 2036 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1The shares subject to the option will vest on the earlier of June 9, 2027 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer.